Our data indicate that although, as described [60], LC3I and LC3II appeared to be enhanced in 3xTg-AD vs Wt mice, shAPA did not modulate LC3 expressions in 12-month-old 3xTg-AD mice brain (data not shown). Here, MAP1LC3A is linked to Alzheimer disease.